Vol. 31 (2) 2024
Association of serum IL-30 and soluble GP130 with the risk of psoriasis vulgaris The Egyptian Journal of Immunology Volume 31 (2), April, 2024 Pages: 61 – 70. www.Ejimmunology.org https://doi.org/10.55133/eji.310207 Rofaida R. Shehata1, Sara A. Atta2, Abd-Elsamea S....
Vol. 31 (2) 2024
Clinical significance of viral markers testing by ELISA and Individual Donation Nucleic Acid Testing (ID-NAT) for blood screening in blood bank: Single center study in Egypt The Egyptian Journal of Immunology Volume 31 (2), April, 2024 Pages: 55 – 60....
Vol. 31 (2) 2024
Vitamin D receptor gene polymorphism in Egyptian multiple sclerosis patients The Egyptian Journal of Immunology Volume 31 (2), April, 2024 Pages: 44 – 54. www.Ejimmunology.org https://doi.org/10.55133/eji.310205 Nermin R. Abdelwahab1, Randa R. Mabrouk1, Nahla M....
Vol. 31 (2) 2024
Plasma metadherin mRNA expression in bladder cancer The Egyptian Journal of Immunology Volume 31 (2), April, 2024 Pages: 28 – 43. www.Ejimmunology.org https://doi.org/10.55133/eji.310204 Zeinab A. Abd Elhameed1, Lubna M. Tag El Din1, Tahra Sherif1, Amal M. Abdel Aal1,...
Vol. 31 (2) 2024
Assessment of Stx-1A gene polymorphism (rs1569061) in relation to the development of multiple sclerosis in Egyptian patients The Egyptian Journal of Immunology Volume 31 (2), April, 2024 Pages: 18 – 27. www.Ejimmunology.org https://doi.org/10.55133/eji.310203...
Vol. 31 (2) 2024
Identification of some variable parameters in serum of COVID-19 patients in comparison with control group The Egyptian Journal of Immunology Volume 31 (2), April, 2024 Pages: 10 – 17. www.Ejimmunology.org https://doi.org/10.55133/eji.310202 Ebtihal C. Abbas1, Mais M....
